We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian generic drugmakers Wockhardt, Strides Arcolab and Unichem
have all recently announced significant expansions to their businesses in Latin
America.
Local reports claim that Swiss drug major Novartis intends to buy
a generic drugmaker in Germany, and the company is allegedly in negotiations
with the country's second-largest producer, Hexal AG.
Official sources indicate that Chinese industrial groups are moving
to enhance their distribution presence in the country's fast-developing drug
market.
A number of local companies have claimed that India's new
Value Added Tax sales tariff, to be introduced on April 1, will benefit market
conditions across the economy, including the pharmaceuticals sector.
The health ministry of the United Arab Emirates (UAE) has refused
to approve 30 new products on the grounds that the suggested pricing put forward
by local drugmakers is excessive.
Brazil's state development bank, the BNDES, has announced
that it is to increase its investment in local drug producers and focus on biotechnology
ventures.